Thrombosis in the presence of vascular stasis.

[1]  A. Ochsner.  Thrombophlebitis and phlebothrombosis. , 1953, The Medical clinics of North America.

[2]  S. Wessler,et al.  Studies in intravascular coagulation. II. A comparison of the effect of dicumarol and heparin on clot formation in isolated venous segments. , 1953, The Journal of clinical investigation.

[3]  E. Warner,et al.  Further Experience With the Use of Thrombin as a Hemostatic Agent∗ , 1939 .

[4]  S. Cohen,et al.  The temporary thrombotic state; application of this concept to the therapy of recurrent thromboembolism, with bacteriologic and roentgenologic considerations in the differential diagnosis of pulmonary infarction and pneumonia. , 1956, The New England journal of medicine.

[5]  S. Wessler,et al.  Serum thrombotic accelerator (STA) activity: a possible key to massive venous thromboembolism in man. , 1961, Transactions of the Association of American Physicians.

[6]  M. Verstraete.  The complexity of the dicoumarol effect. , 1960, Archives internationales de pharmacodynamie et de therapie.

[7]  J. Flynn.  Blood clotting and allied problems : transactions of the Fifth Conference February 16-17, 1948, New York , 1948 .

[8]  J. Poole.  A study of artificial thrombi produced by a modification of Chandler's method. , 1959, Quarterly journal of experimental physiology and cognate medical sciences.

[9]  H. Eagle,et al.  Coagulation of Blood by Proteolytic Enzymes (Trypsin, Papain) , 1936 .

[10]  S. Wessler,et al.  Studies in Intravascular Coagulation: IV. The Effect of Heparin and Dicumarol on Serum‐Induced Venous Thrombosis , 1955, Circulation.

[11]  R. Rosenfield,et al.  Estimation of prothrombin level from prothrombin time. , 1947, American journal of clinical pathology.

[12]  S. Wessler,et al.  Experimental pulmonary embolism with serum-induced thrombi. , 1961, The American journal of pathology.

[13]  D. Spain,et al.  THE RELATIONSHIP OF CORONARY THROMBOSIS TO CORONARY ATHEROSCLEROSIS AND ISCHEMIC HEART DISEASE: (A NECROPSY STUDY COVERING A PERIOD OF 25 YEARS) , 1960 .

[14]  P. Nicola,et al.  HEMOPHILIA AND OTHER HEMORRHAGIC STATES , 1961 .

[15]  B. Alexander,et al.  A prothrombin activator in serum, and its significance in certain hemorrhagic diseases. , 1948, The Journal of clinical investigation.

[16]  E. Henderson,et al.  The thrombotic activity of activation product. , 1962, The Journal of clinical investigation.

[17]  S. Wessler,et al.  The role of human coagulation factors in serum-induced thrombosis. , 1960, The Journal of clinical investigation.

[18]  P. Nicola.  Analytical Review: Factor VII (SPCA) , 1953 .

[19]  B. Alexander.  Blood Coagulation and Thrombotic Disease , 1962, Circulation.

[20]  I. Gore,et al.  Pulmonary arterial bands and webs: an unrecognized manifestation of organized pulmonary emboli. , 1962, The American journal of pathology.

[21]  S. Shapiro,et al.  THE PREVENTION OF THE GENERALIZED SHWARTZMAN REACTION WITH SODIUM WARFARIN , 1958, The Journal of experimental medicine.

[22]  J. B. Duguid.  Thrombosis as a factor in the pathogenesis of coronary atherosclerosis. , 1946, The Journal of pathology and bacteriology.

[23]  R. Virchow,et al.  Gesammelte Abhandlungen zur wissenschaftlichen Medicin , 1856 .

[24]  T. Spaet,et al.  Effect of Intravenous Soy Bean Phosphatides on Blood Coagulation in Rabbits.∗ , 1957, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[25]  J. Fine,et al.  Biological implications of intestinal endotoxins. , 1962, Federation proceedings.

[26]  S. Mudd.  BLOOD SUBSTITUTES AND BLOOD TRANSFUSION , 1943 .

[27]  M. Horwitz,et al.  The uricosuric action of ethyl biscoumacetate. , 1955, Lancet.

[28]  A. Quick.  ON THE ACTION OF HEPARIN AND ITS RELATION TO THROMBOPLASTIN , 1936 .

[29]  M. J. Schlesinger,et al.  Studies in Peripheral Arterial Occlusive Disease: I. Methods and Pathologic Findings in Amputated Limbs , 1953, Circulation.

[30]  S. Wessler,et al.  Studies in intravascular coagulation. III. The pathogenesis of serum-induced venous thrombosis. , 1955, The Journal of clinical investigation.

[31]  E. Robin,et al.  Gas exchange after autologous pulmonary embolism in dogs , 1961 .

[32]  P. Owren.  Thrombotest. A new method for controlling anticoagulant therapy. , 1959, Lancet.

[33]  S. Ming,et al.  A Critical Evaluation of Thromboangiitis Obliterans , 1960 .

[34]  S. V. van Creveld,et al.  Proconvertin content in the blood of newborn full-term and premature infants. , 1954, Etudes neo-natales. Neo-natal studies.

[35]  S. Wessler,et al.  Studies in Intravascular Coagulation , 1957 .

[36]  A. Freiman,et al.  Factors affecting the formation and dissolution of experimental thrombi. , 1960, The American journal of cardiology.

[37]  D. Deykin,et al.  Evidence for an antithrombotic effect of Dicumarol. , 1960, American Journal of Physiology.

[38]  V. Gurewich,et al.  Bronchoconstriction in the Presence of Pulmonary Embolism , 1963, Circulation.

[39]  B. Waaler.  Simultaneous contribution to the formation of thrombin by the intrinsic and extrinsic blood clotting systems. , 1957, Scandinavian journal of clinical and laboratory investigation.

[40]  S. Wessler,et al.  Studies in intravascular coagulation. I. Coagulation changes in isolated venous segments. , 1952, The Journal of clinical investigation.

[41]  R. Colman,et al.  Evidence for a new serum thromboplastic factor. , 1960, Tohoku igaku zasshi.

[42]  M. C. Sheps,et al.  Biologic assay of a thrombosis-inducing activity in human serum. , 1959, Journal of applied physiology.

[43]  E. Freis,et al.  THE ACCELERATION OF LINEAR FLOW IN THE DEEP VEINS OF THE LOWER EXTREMITY OF MAN BY LOCAL COMPRESSION. , 1949, The Journal of clinical investigation.

[44]  A. Loeliger,et al.  Behaviour of factor VII and prothrombin in late pregnancy and in the newborn. , 1952, Acta haematologica.

[45]  H. Wright,et al.  The adhesiveness of blood platelets in normal subjects with varying concentrations of anti-coagulants , 1941 .

[46]  S. Wessler,et al.  Thrombosis inducing factors in serum. , 1960, Thrombosis et diathesis haemorrhagica.

[47]  T. R. Seshadri,et al.  Anti-veratrinic activity of coumarin and its derivative compounds. , 1960, Archives internationales de pharmacodynamie et de therapie.

[48]  L. Jaques,et al.  AN ASSAY FOR THE ANTITHROMBOTIC ACTIVITY OF ANTICOAGULANTS , 1959, Journal of clinical pathology.

[49]  B. Landing,et al.  Extraneural lesions associated with neonatal hyperbilirubinemia and kernicterus. , 1962, The American journal of pathology.

[50]  A. Quick.  On the Probable Mechanism of Intravascular Clotting , 1956, Angiology.

[51]  E. Warner,et al.  THE INHIBITION OF BLOOD CLOTTING: AN UNIDENTIFIED SUBSTANCE WHICH ACTS IN CONJUNCTION WITH HEPARIN TO PREVENT THE CONVERSION OF PROTHROMBIN INTO THROMBIN , 1939 .

[52]  Chandler Ab,et al.  Atherosclerotic metamorphosis of autologous pulmonary thromboemboli in the rabbit. , 1962 .

[53]  A. S. Freedberg,et al.  The plasma protein-thyroid hormone complex in man. III. Further studies on the use of the in vitro red blood cell up take of I 131-1-triiodothyronine as a diagnostic test of thyroid function. , 1959, The Journal of clinical endocrinology and metabolism.

[54]  H. Rierson,et al.  Enzymes and blood clotting. I. Trypsin as an accessory factor. , 1960, The Journal of clinical investigation.

[55]  C. Hussey,et al.  THE CLOTTING ACTIVITY OF HUMAN ERYTHROCYTES: THEORETICAL AND CLINICAL IMPLICATIONS* , 1954, The American journal of the medical sciences.

[56]  D. Deykin,et al.  Serum Thrombotic Accelerator (STA) Activity , 1960, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[57]  A. Freiman,et al.  Fibrinolytic (Plasmin) Therapy of Experimental Coronary Thrombi with Alteration of the Evolution of Myocardial Infarction , 1959, Circulation.

[58]  H. Colebatch,et al.  Cardiorespiratory effects of experimental lung embolism. , 1961, The Journal of clinical investigation.

[59]  S. Wessler,et al.  Serum‐Induced Thrombosis: Studies of its Induction and Evolution Under Controlled Conditions in Vivo , 1959, Circulation.

[60]  M. C. Sheps,et al.  Studies in Peripheral Arterial Occlusive Disease: III. Acute Arterial Occlusion , 1958, Circulation.

[61]  R. Macdonald,et al.  The significance of nonbacterial thrombotic endocarditis: an autopsy and clinical study of 78 cases. , 1957, Annals of internal medicine.

[62]  N. Back,et al.  CLINICAL AND EXPERIMENTAL STUDIES ON FIBRINOLYTIC ENZYMES , 1957, Annals of the New York Academy of Sciences.

[63]  H. Eagle,et al.  STUDIES IN BLOOD COAGULATION : V. THE COAGULATION OF BLOOD BY PROTEOLYTIC ENZYMES (TRYPSIN, PAPAIN). , 1937 .

[64]  L. Mcdonald,et al.  Coagulability of the blood in ischaemic heart-disease. , 1957, Lancet.

[65]  M. Stefanini,et al.  Experimental production of phlebothrombosis. , 1960, Surgery, gynecology & obstetrics.

[66]  A. Loeliger,et al.  Experiments on a new clotting factor (factor VII). , 1951, Acta haematologica.

[67]  Chandler Ab.  In vitro thrombotic coagulation of the blood; a method for producing a thrombus. , 1958 .

[68]  J. H. Gibbon,et al.  CHANGES IN THE CIRCULATION PRODUCED BY GRADUAL OCCLUSION OF THE PULMONARY ARTERY. , 1932, The Journal of clinical investigation.

[69]  P. Preziosi,et al.  On the pulmonary and cardiovascular effects of warfarin sodium. , 1959, Archives internationales de pharmacodynamie et de therapie.

[70]  A D MCLACHLIN,et al.  Venous stasis in the lower extremities. , 1960, Annals of surgery.

[71]  I. Wright,et al.  Studies with crystalline trypsin: results and hazards of intravenous administration and its postulated role in blood coagulation. , 1954, Journal of the American Medical Association.

[72]  D. Thomas,et al.  The Relation of Factors XII, XI, and IX to Hypercoagulable States , 1963, Thrombosis and Haemostasis.

[73]  E. Attinger,et al.  Ventilatory responses to embolization of lung. , 1961, Journal of applied physiology.

[74]  B. Alexander,et al.  A factor in serum which accelerates the conversion of prothrombin to thrombin; its evolution with special reference to the influence of conditions which affect blood coagulation. , 1949, Blood.

[75]  Jorpes Je.  Anticoagulant therapy in thrombosis. , 1946, Surgery, gynecology & obstetrics.

[76]  Barrett Rj,et al.  The effect of moderate degrees of dicumarol-induced hypoprothrombinemia on experimental intravascular thrombosis. , 1949 .

[77]  E. Hook,et al.  Activation of platelet factor 3 by bacterial endotoxin in rabbits , 1962 .

[78]  E. Mandel,et al.  Lipemia-Induced Acceleration of Intravascular Clotting.∗ , 1959, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[79]  Thomas E. Nelson.  Effect of Dicumarol on Blood Vascular Integrity in the Rabbit , 1960, Circulation research.

[80]  H. Wright.  The adhesiveness of blood platelets in rabbits treated with dicoumarol , 1945 .

[81]  S. Wessler,et al.  Experimental pulmonary embolism with serum-induced thrombi aged in vivo. , 1961, The American journal of pathology.